4.6 Article

Substantial variation in the cardiac differentiation of human embryonic stem cell lines derived and propagated under the same conditionsa comparison of multiple cell lines

Journal

ANNALS OF MEDICINE
Volume 41, Issue 5, Pages 360-U17

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1080/07853890802609542

Keywords

Cardiac; differentiation; gene expression; human embryonic stem cells

Funding

  1. Academy of Finland
  2. Finnish Heart Research Foundation
  3. Finnish Cultural Foundation
  4. Competitive Research Funding of Pirkanmaa Hospital District
  5. Kalle Kaihari Foundation
  6. Ida Montin Foundation
  7. BioneXt Tampere

Ask authors/readers for more resources

Aim. The differentiation efficiencies of human embryonic stem cell (hESC) lines differ from each other. To assess this in more detail we studied the cardiac differentiation of eight hESC lines derived in the same laboratory. Results. Substantial variation in growth and in the ability to form beating areas was seen between the different hESC lines; line HS346 gave the best efficiency (9.4%), while HS293 did not differentiate into beating colonies at all. Nine germ layer and differentiation markers were quantified during early differentiation in four hESC lines. The expression levels of Brachyury T, MESP1 and NKX2.5 were highest in the most efficient cardiac line (HS346). A systematic characterization of the beating cells revealed proper cardiac marker expression, electrophysiological activity, and pharmacological response. Conclusions. The hESC lines derived in the same laboratory varied considerably in their potential to differentiate into beating cardiomyocytes. None of the expression markers could clearly predict cardiac differentiation potential, although the expression of early cardiomyogenic genes was upregulated in the best cardiac line. The proper cardiomyocyte characteristics and pharmacological response indicate that these cells could be used as a model for human cardiomyocytes in pharmacological and toxicological analyses when investigating new heart medications or cardiac side-effects.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available